Found 117 matching trials
Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection PHASE3 The primary objectives of this study are to evaluate the efficacy, safety, ...
Show More Location
Multiple Locations
Learn More & Join Trial
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis PHASE4 This study will examine the safety, tolerability, and antiviral efficacy of...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study PHASE2 The primary objective of this study is to evaluate the efficacy, safety and...
Show More Location
Multiple Locations
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy PHASE2 The primary objectives of this study are to evaluate the efficacy, safety, ...
Show More Location
National Cancer Institute, Cairo University
Learn More & Join Trial
GS-7977 With Ribavirin for Hepatitis C (SPARE) PHASE1 Background:
\- GS-7977 is a new drug that is being developed to treat hepa...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection PHASE3 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection PHASE3 This study will assess the efficacy, safety, and tolerability of 16 or 24 w...
Show More Location
Multiple Locations
Learn More & Join Trial
Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea N/A The primary objective of this post-marketing surveillance study is to colle...
Show More Location
CHA Bundang Medical Center
Learn More & Join Trial